37 records, the earliest from 3 Jan 2018. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
37 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 3 Sep 2026 | Other business matters | To consider other business matters |
| 20 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 14 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 14 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 9 Jan 2026 | Other business matters | To consider other business matters (a) acquisition of equity shares of a target company from certain shareholders of the target company; (b) issue certain equity shares to the shareholders of the target company on a preferential basis through the private placement route, as consideration other than cash in lieu of the acquired shares and(c) to consider and approve the Employee Stock Option Plan (ESOP). |
| 14 May 2024 | Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| 7 Nov 2023 | Financial Results/Other business matters | 1.To consider and approve the financial results for the period ended September 30, 2023 .2. To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of National Stock Exchange of India Limited & Bombay Stock Exchange of India Limited. |
| 8 May 2023 | Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| 27 Oct 2022 | Financial results | Beta Drugs Limited has informed the Exchange about Board Meeting to be held on 27-Oct-2022 to consider financial statements for the period ended September 2022 |
| 27 Apr 2022 | Financial results | Beta Drugs Limited has informed the Exchange about Board Meeting to be held on 27-Apr-2022 to consider financial statements for the period ended March 2022 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
